GPC1 and breast cancer: That α3(V)-GPC1 interactions are functionally important is supported by the observations that α3(V) ablation results in reduced mammary tumour cell proliferation, Ras/Erk signalling, and cell cycle progression—just those properties stimulated by GPC1.